Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
July 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
December 31, 2012
Conditions
Healthy Male Subjects
Interventions
DRUG
Exforge tab. 10/160mg
DRUG
Lodivixx tab. 5/160mg
Trial Locations (1)
614-735
Inje University Busan Paik Hospital, Busan
All Listed Sponsors
lead
Hanlim Pharm. Co., Ltd.
INDUSTRY
NCT01652339 - Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects | Biotech Hunter | Biotech Hunter